HOOK

HOOKIPA Pharma Inc
1.00
-0.01 (-0.99%)
Upgrade to Real-Time
Regular Market
1.00
Volume 143,522
Bid Price 0.999
Ask Price 1.01
News -
Day High 1.05

Low
0.72

52 Week Range

High
3.05

Day Low 0.9985
Company Name Stock Ticker Symbol Market Type
HOOKIPA Pharma Inc HOOK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.01 -0.99% 1.00 15:00:01
Open Price Low Price High Price Close Price Prev Close
1.00 0.9985 1.05 1.01
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
413 143,522 $ 1.02 $ 145,940 - 0.72 - 3.05
Last Trade Time Type Quantity Stock Price Currency
15:00:01 658 $ 1.00 USD

Period:

Draw Mode:

HOOKIPA Pharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 54.72M 54.72M 46.44M $ 18.45M $ - -2.30 -0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 0.80%

more financials information »

HOOKIPA Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical HOOK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.991.050.960.9963107207,2090.011.01%
1 Month0.8721.100.83520.9755245214,4910.12814.68%
3 Months1.261.300.720.943869326,044-0.26-20.63%
6 Months1.471.770.721.21632,664-0.47-31.97%
1 Year1.383.050.721.972,120,188-0.38-27.54%
3 Years12.1620.000.723.00820,589-11.16-91.78%
5 Years14.0020.000.723.17668,819-13.00-92.86%

HOOKIPA Pharma Description

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.